How low is the risk of influenza A(H5N1) infection?

Journal of Infectious Diseases

Volumn 211, Issue 9, 2015, Pages 1364-1366

  Morens, David M ^a   Taubenberger, Jeffery K ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

H5N1; H7N9; Influenza; Pandemic; Seroepidemiology; Serology

Indexed keywords

NEUTRALIZING ANTIBODY;

ANTIBODY RESPONSE; ANTIBODY TITER; AVIAN INFLUENZA VIRUS; CELLULAR IMMUNITY; EGYPT; EPIDEMIC; HUMAN; INFECTION RISK; INFLUENZA A (H5N1); INFLUENZA VIRUS A H5N1; NONHUMAN; NOTE; PRIORITY JOURNAL; SEROPREVALENCE; VIRUS VIRULENCE; FEMALE; INFLUENZA VIRUS A H9N2; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MALE; VIROLOGY;

FEMALE; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA A VIRUS, H9N2 SUBTYPE; INFLUENZA, HUMAN; MALE;

EID: 84928911095     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu530     Document Type: Note

References (29)

1. Russell CA, Fonville JM, Brown AE, et al. The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science 2012; 336:1541-7.
2. World Health Organization. Cumulative number of confirmed human cases of avian influenza A(H5N1) reported to WHO. http://www. who.int/influenza/humananimalinterface/EN-GIP-20140124CumulativeNumberH5N 1 cases.pdf?ua=1. Accessed 9 October 2014.
3. Sample I. Scientists condemn 'crazy, dangerous' creation of deadly airborne flu virus. The Guardian. 11 June 2014. http://www. theguardian.com/science/2014/jun/11/crazy-dangerous-creation-deadly-airborne-flu-virus. Accessed 9 October 2014.
4. The Cambridge Working Group. Cambridge Working Group Consensus Statement on the Creation of Potential Pandemic Pathogens (PPPs). http://www.cambridgeworkinggroup. org. Accessed 9 October 2014.
5. Patterson AP, Tabak LA, Fauci AS, Collins FS, Howard S. Research funding. A framework for decisions about research with HPAI H5N1 viruses. Science 2013; 339:1036-7.
6. Lipsitch M, Galvani AP. The case against 'gain-of-function' experiments: A reply to Fouchier & Kawaoka. CIDRAP Newsletter. 29 June 2014. http://www.cidrap.umn.edu/news-perspective/2014/06/commentary-case-against-gain-function-experiments-reply-fouchier-kawaoka. Accessed 9 October 2014.
7. Lipsitch M, Drexler M. When Lab research threatens humanity. Harvard Public Health Rev 2014; Fall, 9-9. https://cdn1.sph.harvard. edu/wp-content/uploads/sites/21/2014/09/When-Lab-Research-Threatens-Humanity-Q-and-A.pdf Accessed 9 October 2014.
8. Wang TT, Parides MK, Palese P. Seroevi-dence for H5N1 influenza infections in humans: meta-analysis. Science 2012; 335:1463.
9. Gomaa MR, Kayed AS, Elabd MA, et al. Avian influenza A(H5N1) and A(H9N2) se-roprevalence and risk factors for infection among Egyptians: a prospective, controlled seroepidemiological study. J Infect Dis 2015; 211:1399-407.
10. Khuntirat BP, Yoon IK, Blair PJ, et al. Evidence for subclinical avian influenza virus infections among rural Thai villagers. Clin Infect Dis 2011; 53:e107-16.
11. Krueger WS, Khuntirat B, Yoon IK, et al. Prospective study of avian influenza virus infections among rural Thai villagers. PLoS One 2013; 8:e72196.
12. Okoye JO, Eze DC, Krueger WS, et al. Evidence for subclinical H5N1 avian influenza infections among Nigerian poultry workers. J Med Virol 2014; doi:10.1002/jmv.23909.
13. Morens DM, Subbarao K, Taubenberger JK. Engineering H5N1 avian influenza viruses to study human adaptation. Nature 2012; 486:335-40.
14. Morens DM. Pandemic H5N1: Receding risk or coming catastrophe? Clin Infect Dis 2013; 56:1213-5.
15. Morens DM, Taubenberger JK, Fauci AS. Pandemic influenza viruses-hoping for the road not taken. N Engl J Med 2013; 368: 2345-8.
16. Everitt AR, Clare S, Pertel T, et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 2012; 484:519-23.
17. Horby P, Sudoyo H, Viprakasit V, et al. What is the evidence of a role for host genetics in susceptibility to influenza A/H5N1? Epidemiol Infect 2010; 138:1550-8.
18. World Health Organization. Summary of human infection with highly pathogenic avian influenza A (H5N1) virus reported to WHO, January 2003-March 2009: cluster-associated cases. Wkly Epidemiol Rec 2010; 85:13-20.
19. Aditama TY, Samaan G, Kusriastuti R, et al. Risk factors for cluster outbreaks of avian influenza A H5N1 infection, Indonesia. Clin Infect Dis 2011; 53:1237-44.
20. Aditama TY, Samaan G, Kusriastuti R, et al. Avian i nfluenza H5N1 transmission in households, Indonesia. PLoS One 2012; 7:e29971.
21. Beare AS, Webster RG. Replication of avian influenza viruses in humans. Arch Virol 1991; 119:37-42.
22. Powell TJ, Fox A, Peng Y, et al. Identification of H5N1-specific T-cell responses in a high-risk cohort in Vietnam indicates the existence of potential asymptomatic infections. J Infect Dis 2012; 205:20-7.
23. Saw TA, Lim W, Shortridge K, et al. Update: isolation of avian influenza A (H5N1) viruses from humans-Hong Kong, 1997-1998. MMWR Morb Mortal Wkly Rep 1998; 46:1245-7.
24. Katz JM, Lim W, Bridges CB, et al. Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. J Infect Dis 1999; 180: 1763-7.
25. Lu C-Y, Lu J-H, Chen W-Q, et al. Potential infections of H5N1 and H9N2 avian influenza do exist in Guangdong populations of China. China Med J 2008; 121:2050-3.
26. Cao N, Zhu W, Chen Y, et al. Influenza A (H5N1) virus antibodies in pigs and residents of swine farms, southern China. J Clin Virol 2013; 58:647-51.
27. Wang X, Fang S, Lu X, et al. Seroprevalence to avian influenza A(H7N9) virus among poultry workers and the general population in southern China: a longitudinal study. Clin Infect Dis 2014; 59:e76-83.
28. Morens DM, Taubenberger JK, Fauci AS. The persistent legacy of the 1918 influenza virus [published correction appears in N Engl J Med 2009; 361:1123]. N Engl J Med 2009; 361:225-9.
29. Morens DM, Taubenberger JK. Pandemic influenza: certain uncertainties. Rev Med Virol 2011; 21:262-84.